Takeaways from ESPT 2019

The 5th International Congress of the European Society of Pharmacogenomics and Personalized Therapy (ESPT 2019) was held inSeville, Spain, from Oct. 16-18, 2019.  The conference addressed the research progress and

Government Health Initiatives Prioritize Pharmacogenetic Research

Pharmacogenomics promises to offer better treatment outcomes, fewer side effects, and a more personalized healthcare experience. To deliver on this promise, PGx must reach a wide audience, not just those with the

Implementing a Pharmacogenomics Program in a Large-Scale Rural Based Healthcare System

Most PGx programs operate in large academic medical centers within densely populated urban areas. These communities are often already rich in healthcare resources. But what about more rural populations?

PGx Testing Programs: A Win-Win for Both Employers and Employees

Today’s workforce wants more from its jobs and its employers. In a tight labor market with low unemployment, companies must find new ways to attract, engage and retain their best workers. Investing in employees

The Role of Clinical Pharmacogenomics in Managing Patient Expectations

By the end of 2018, more than 26 million consumers had undergone direct-to-consumer (DTC) genetic testing. These genetic tests promise to identify medically relevant genetic variants, identify a consumer’s genetic